Improving gene editing techniques in the worm C. elegans
Genome engineering in the nematode C. elegans
This study is working on making it easier and faster to edit genes using a special tool called CRISPR in tiny worms called C. elegans, which could help scientists learn more about how genes work and improve research in biology.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11007259 on NIH RePORTER |
What this research studies
This research focuses on enhancing gene editing methods using CRISPR technology in the model organism C. elegans, a type of nematode. The project aims to simplify and speed up the process of tagging genes, which is crucial for understanding their functions. By developing new techniques that allow multiple genes to be modified simultaneously, the researchers hope to make genetic engineering more efficient and accessible. This could lead to significant advancements in biological research and applications.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with genetic conditions that could be studied or treated through advancements in gene editing.
Not a fit: Patients with conditions unrelated to genetic modifications in model organisms like C. elegans may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could greatly enhance our ability to study gene functions and develop new treatments for genetic disorders.
How similar studies have performed: Other research has shown success with CRISPR techniques in various organisms, indicating a promising potential for this approach in C. elegans.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Jorgensen, Erik M — University of Utah
- Study coordinator: Jorgensen, Erik M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.